{"id":"W2001129294","doi":"10.1016/j.clinthera.2005.08.001","title":"Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C β-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial","year":2005,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto","funders":"Eli Lilly and Company; American Diabetes Association","keywords":"Medicine; Mesylate; Placebo; Peripheral neuropathy; Double blind; Protein kinase C; Peripheral; Clinical trial; Randomized controlled trial; Internal medicine; Pharmacology; Kinase; Diabetes mellitus; Endocrinology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00288227,0.002214881,0.005454803,0.0006766459,0.0007386436,0.001202587,0.001108525,0.003027645,0.004426678],"category_scores_gemma":[0.002092839,0.0009473979,0.002210492,0.0006430813,0.001669129,0.001454007,0.0004479034,0.003105955,0.0008673721],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000639986,"about_ca_system_score_gemma":0.001161234,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001041696,"about_ca_topic_score_gemma":0.001673339,"domain_scores_codex":[0.9988546,0.0005306055,0.00009090736,0.0001845616,0.00008381777,0.000255499],"domain_scores_gemma":[0.9988906,0.0002956934,0.0002378895,0.000101278,0.00009328493,0.0003813566],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9873395,0.003751451,0.0001966433,0.0003436134,0.0003481073,0.00001929572,0.00002641792,0.0001266548,0.001716599,0.00003656592,0.0001884267,0.005906669],"study_design_scores_gemma":[0.9297405,0.06806633,0.001129071,0.00002288426,0.0002620177,0.00001384868,0.00001415382,0.0001785329,0.0003166537,0.00004196879,0.0002030437,0.00001095835],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9844025,0.006760097,0.0010328,0.0005159882,0.000752557,0.003875457,0.0006242082,0.0001853569,0.00185095],"genre_scores_gemma":[0.9850138,0.004366693,0.001260348,0.001028378,0.0007279931,0.004263875,0.0009495246,0.00002614775,0.00236315],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005454803,"threshold_uncertainty_score":0.01524311,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07598269146664982,"score_gpt":0.3738358848961089,"score_spread":0.297853193429459,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}